Effects of Interleukin-2 and Interferon Treatment on Tumor Growth in Mice
Author Information
Author(s): M. Jigo, Y. Nakajima, K. Nishikata, A. Hoshi
Primary Institution: National Cancer Centre Research Institute
Hypothesis
The combination of interleukin-2 and interferon will enhance antitumor activity compared to either treatment alone.
Conclusion
The combination of interleukin-2 and interferon significantly reduces tumor size and alters lymphocyte populations in tumor-bearing mice.
Supporting Evidence
- Combined treatment with rHIL-2 and rIFN-aA/D resulted in a substantial reduction in tumor size.
- Injection of cytokines increased the total number of lymphocytes in the peritoneal cavity.
- Frequency of Lyt-2+/L3T4- T-cells correlated with antitumor activity.
Takeaway
Giving mice a mix of two special proteins helps their bodies fight tumors better than just one protein alone.
Methodology
Mice were treated with interleukin-2 and interferon, and their tumor growth and lymphocyte populations were analyzed.
Limitations
The study was conducted on a specific mouse strain and may not be generalizable to other models.
Participant Demographics
Inbred, 5-week-old, male C57BL/6 mice.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website